Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/terbinafine-shows-lowest-hepatotoxicity-risk-patients-2026a1000azh?src=rss
Author :
Publish date : 2026-04-10 10:05:00
Copyright for syndicated content belongs to the linked Source.